Follicular dendritic cell sarcoma arises from the follicular dendritic cells present in the lymph nodes, especially of the head and neck area. Rarely, extranodal sites may be affected including tonsil, the oral cavity, liver, spleen and the gastrointestinal tract. Here, we report a case of intra-abdominal follicular dendritic cell sarcoma presenting as a huge mass in the ileocecal region of a 24-year young woman.
Introduction
Fol licular dendritic cell (FDC) sarcoma is an extremely Fol licular dendritic cell (FDC) sarcoma is an extremely F rare neoplasm arising from dendritic cells of germinal centers. Approximately 30% of the cases are reported to have been located at extranodal sites, such as the liver, tonsil and intra-abdominal soft tissue. 1 Involvement of the gastrointestinal tract is extremely rare. To our knowledge, only five cases have been described to date and these were mostly located in the colon and retroperitoneum. 2, 3 We report of a case of follicular dendritic cell sarcoma involving the ileocaecal region of the gastrointestinal tract of a 24-year-old woman.
Case Report
A 24-year-old female presented with complaints of intermittent pain in the right iliac fossa for one year and heaviness in the lower abdomen for four months. There was no history of vomiting, abdominal distension, bleeding per rectum, fever, or past history of tuberculosis. On physical examination, there was a firm, nontender lump, palpable in the right iliac fossa. Ultrasonography of the whole abdomen showed ileocolic intussusception with suspicious hypoechoic space-occupying lesion (SOL). CT scan of the whole abdomen ( Fig. 1) was suspicious for ileocolic intussusception with thickened ileal wall. Proximal small bowel loops were not distended. One globular, relatively well-defined SOL (68 × 74 mm) was noted anterior to the ascending colon and cecum. The mass was heterogeneously enhancing with small irregular hypodense area, adherent with cecum. Another globular mass (68 × 99 mm) of similar attenuation with necrotic centre was noted in the lower paravertebral location extending to the right iliac fossa. Fewer much smaller but similar globular masses were also noted in the prevertebral location below the horizontal level of the kidneys. All these globular masses were adherent with each other, but no ascites were noted besides the aorta and IVC were normal. USG-guided FNAC showed poorly differentiated carcinoma. Serum CEA was 0.5 ng/mL, LDH was 579.2 U/L and other routine laboratory examination and chest X-ray were all normal. The patient then underwent right hemicolectomy with excision of the retroperitoneal mass. On gross examination, a polypoid tumor was seen at the ileocecal region, 6.5 cm in its greatest axis and the peri-intestinal fibro-fatty tissue showed five fleshy nodular masses, the largest measuring 11 cm in its greatest axis. Histopathological examination of both masses showed a tumor composed of interlacing fascicles of spindle-shaped cells with elongated, plump nuclei admixed with non-neoplastic small lymphocytes (Fig. 2) . The tumor cells showed nuclear pleomorphism and 7-8 mitotic figures per 10 high power fields. At places, the tumor cells were arranged in a vaguely storiform pattern. The mucosa overlying the tumor in the ileocecal region was ulcerated. The histological picture was suspicious for follicular dendritic cell sarcoma. The surgical lines of resection were free of lesion.
On immunohistochemistry, the tumor cells express CD35, CD23, and CD21 (Figs. 3 and 4) and was immunonegative for CD34, CD45, CD19, c-kit, DOG-1, EMA, CK, EBV, Desmin, SMA and S-100 protein. Thus, the diagnosis of follicular dendritic cell sarcoma was confirmed. CT scan of the whole abdomen (Fig.  5 ) after 6 months of operation showed no abnormality in the abdomen. No adjuvant treatment was recommended for this patient. Follow-up was done with monthly clinical examination and CT scan of whole abdomen every six months for the last one year and showed no recurrence. 
Discussion
FDC sarcoma is a very rare neoplasm. It was first described in 1986 by Monda et al. and there are less than 80 cases reported in the English literature. [4] [5] [6] [7] This neoplasm affects both sexes equally, and the disease occurs over a wide age range from 14 to 77 years (mean age: 47 years). The disease typically presents as a painless, slow growing, well-defined mass lesion at the involved site. 8 Microscopically, follicular dendritic cell tumors are composed of oval to spindle cells with eosinophilic cytoplasm arranged in sheets, fascicles and whorls, sometimes admixed with foci showing a storiform pattern of growth, suggesting a diagnosis of sarcoma. The tumor cells are characteristically admixed with small lymphocytes, leading to an occasional misdiagnosis of lymphoma. The differential diagnosis includes Hodgkin's disease, sarcoma, leiomyosarcoma, gastrointestinal stromal tumor, and inflammatory pseudotumor. 9, 10 The diagnosis of FDCS requires a high index of suspicion and requires confirmation by immunohistochemical stains. CD21 and CD35 directed against the C3d and C3b receptors are the most commonly used FDCS markers and these stains can be done on formalin-fixed paraffin embedded materials. 11 Clusterin and fascin are the recently employed markers. 12 The etiology and predisposing factors for FDCS are not ascertained; however, association with Epstein-Barr infection has been suggested, particularly in extranodal FDCS involving the liver. 13 Follicular dendritic cell sarcoma is considered to be an indolent tumor with low tendency for recurrence or metastasis. Previous case reports suggest that the clinical course is variable; some patients had a prolonged indolent course, whereas others die as a result of disease progression. 6 The behavior of these tumors is more akin to that of a low-grade soft tissue sarcoma than a malignant lymphoma, and is characterized by local recurrence in 36% of cases and metastases in 28%. 10 Various treatment modalities have been used to treat this tumor, including surgery, chemotherapy and radiation therapy.
Complete surgical resection is the treatment of choice whenever feasible. Adjuvant radiotherapy or chemotherapy appears to be indicated in cases having adverse pathological features and in recurrent or incompletely resected lesions. Cases with microscopic features such as significant cytological atypia, extensive coagulative necrosis, high proliferative index (mitotic count of >5/10 hpf), or tumor size greater than 6 cm have poor prognosis, whereas lesions arising in the lymph nodes behave as low-grade sarcoma with a relatively good prognosis. 11 No definite therapeutic approach has demonstrated consistent efficacy. 8 In this case, CT scan of the whole abdomen showed two large heterogeneously enhancing masses in the ileocecal region. The patient underwent excision of the masses but did not receive any adjuvant treatment since the tumor was completely resected with adequate margin. No recurrence was detected after one year of follow-up.
Conclusion
Follicular dendritic cell sarcoma should be considered as a differential diagnosis of spindle cell tumor like gastrointestinal stromal tumor, where complete surgical resection seems to be curative without necessitating any adjuvant therapy; however, follow-up is essential in the case of FDC sarcoma.
